1. Home
  2. TLYS vs CGTX Comparison

TLYS vs CGTX Comparison

Compare TLYS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$3.94

Market Cap

128.1M

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$0.94

Market Cap

102.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
CGTX
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.1M
102.9M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
TLYS
CGTX
Price
$3.94
$0.94
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$2.00
$3.33
AVG Volume (30 Days)
221.0K
2.6M
Earning Date
06-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
62.79
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.55
52 Week High
$5.90
$3.83

Technical Indicators

Market Signals
Indicator
TLYS
CGTX
Relative Strength Index (RSI) 41.27 38.01
Support Level $3.68 $0.55
Resistance Level $4.59 $1.19
Average True Range (ATR) 0.31 0.08
MACD -0.02 -0.02
Stochastic Oscillator 11.88 8.90

Price Performance

Historical Comparison
TLYS
CGTX

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley, among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: